H, K., K, S., K, M., T, S., Y, O., & Y, I. (2022). Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity. Immunologic research, 70(3), 414. https://doi.org/10.1007/s12026-022-09273-0
Chicago Style (17th ed.) CitationH, Kasahara, Shimizu K, Makioka K, Sano T, Ohtaki Y, and Ikeda Y. "Multimodal Immunotherapy Ameliorates Myasthenia Gravis Preceded by Thymoma-associated Multiorgan Autoimmunity." Immunologic Research 70, no. 3 (2022): 414. https://doi.org/10.1007/s12026-022-09273-0.
MLA (9th ed.) CitationH, Kasahara, et al. "Multimodal Immunotherapy Ameliorates Myasthenia Gravis Preceded by Thymoma-associated Multiorgan Autoimmunity." Immunologic Research, vol. 70, no. 3, 2022, p. 414, https://doi.org/10.1007/s12026-022-09273-0.